SNAP Tool for Head and Neck Cancer
(SNAP Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications. It is best to consult with the trial coordinators or your healthcare provider for guidance.
What data supports the effectiveness of the SNAP tool treatment for head and neck cancer?
The SNAP tool for head and neck cancer is being tested for its acceptability and feasibility, focusing on improving the care of cancer survivors by addressing their needs after treatment. While there is no direct evidence of its effectiveness yet, similar tools like the Survivor Unmet Needs Survey have shown strong properties in assessing the needs of cancer survivors, suggesting potential benefits.12345
Is the SNAP tool safe for use in humans?
How is the SNAP tool treatment different from other treatments for head and neck cancer?
The SNAP tool is unique because it focuses on assessing and planning for the specific needs of head and neck cancer survivors and their caregivers, rather than directly treating the cancer itself. It aims to improve the quality of life by addressing psychosocial challenges and unmet needs after cancer treatment.34589
What is the purpose of this trial?
In this randomized behavioral intervention, head and neck cancer (HNC) survivors and their caregivers (N=176 HNC survivor-caregiver dyads) will be randomized to either Survivorship Needs Assessment Planning (SNAP) or Usual Care (UC) groups to examine the effects of SNAP on outcomes. SNAP includes two sessions with a needs assessment and tailored care plan and a supportive mobile app after completion of radiation to promote uptake of recommended medical and supportive care. The study aims to evaluate the effects of SNAP on symptom severity in patients and caregiver burden in caregivers. Secondary outcomes include psychological distress (anxiety and depression), healthcare utilization (receipt of recommended care) and unmet needs and self-efficacy in HNC survivor-caregiver dyads. Participants will complete surveys at baseline, 6 months, and 9 months post randomization with validated PROMs, and receive intervention modules at the end of radiation and month 3. Participants in the SNAP group will also receive mobile app support.
Research Team
Katherine R Sterba, PhD, MPH
Principal Investigator
Medical University of South Carolina
Eligibility Criteria
This trial is for adults over 18 with non-metastatic head and neck cancer (various types) who are currently undergoing radiation, possibly alongside surgery or chemotherapy. They must aim to cure their cancer and be able to nominate a caregiver willing to participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Radiation
Participants complete radiation treatment, during which the SNAP intervention begins with a caregiver module
SNAP Intervention
Participants in the SNAP group receive two intervention sessions with needs assessment, tailored care plan, and supportive mobile app
Follow-up
Participants are monitored for outcomes such as symptom severity, caregiver burden, and psychological distress
Treatment Details
Interventions
- Survivorship Needs Assessment Planning (SNAP) tool
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical University of South Carolina
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
National Institutes of Health (NIH)
Collaborator